<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(10)</volume><submitter>Sato K</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>Excess salt intake is a major modifiable risk factor for hypertension and cardiovascular disease. Personalized interventions using genetic information and digital tools, such as smartphone applications, may enhance sodium reduction, but evidence remains limited.&lt;h4>Objective&lt;/h4>To evaluate the effectiveness of a sodium reduction program incorporating a genetic profile and an artificial intelligence (AI)-based mobile app among adults with elevated blood pressure and a sodium-sensitive genotype.&lt;h4>Design, setting, and participants&lt;/h4>A 3-arm randomized clinical trial, conducted at a Japanese electronics company from September 17 to December 16, 2024, included employees aged 20 to 65 years with elevated blood pressure and the sodium-sensitive AGT M235T genotype.&lt;h4>Inter</pubmed_abstract><journal>JAMA network open</journal><pagination>e2537540</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12531883</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Sodium Reduction Program Incorporating Genetic Profile and an AI-Based App: A Randomized Clinical Trial.</pubmed_title><pmcid>PMC12531883</pmcid><pubmed_authors>Yanagisawa T</pubmed_authors><pubmed_authors>Yagi M</pubmed_authors><pubmed_authors>Yamaguchi T</pubmed_authors><pubmed_authors>Mizuno S</pubmed_authors><pubmed_authors>Node K</pubmed_authors><pubmed_authors>Akiyama N</pubmed_authors><pubmed_authors>Kondo N</pubmed_authors><pubmed_authors>Sato K</pubmed_authors><pubmed_authors>Inoue K</pubmed_authors><pubmed_authors>Furukawa TA</pubmed_authors><pubmed_authors>Ebisawa M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sodium Reduction Program Incorporating Genetic Profile and an AI-Based App: A Randomized Clinical Trial.</name><description>&lt;h4>Importance&lt;/h4>Excess salt intake is a major modifiable risk factor for hypertension and cardiovascular disease. Personalized interventions using genetic information and digital tools, such as smartphone applications, may enhance sodium reduction, but evidence remains limited.&lt;h4>Objective&lt;/h4>To evaluate the effectiveness of a sodium reduction program incorporating a genetic profile and an artificial intelligence (AI)-based mobile app among adults with elevated blood pressure and a sodium-sensitive genotype.&lt;h4>Design, setting, and participants&lt;/h4>A 3-arm randomized clinical trial, conducted at a Japanese electronics company from September 17 to December 16, 2024, included employees aged 20 to 65 years with elevated blood pressure and the sodium-sensitive AGT M235T genotype.&lt;h4>Inter</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-07-15T12:08:54.686Z</modification><creation>2026-07-04T03:11:54.264Z</creation></dates><accession>S-EPMC12531883</accession><cross_references><pubmed>41100086</pubmed><doi>10.1001/jamanetworkopen.2025.37540</doi></cross_references></HashMap>